| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic was found in Oracle Siebel Clinical up to 8.2.2.x. This issue affects some unknown processing of the component Web UI. Executing a manipulation can lead to an unknown weakness. This vulnerability is tracked as CVE-2012-1674. No exploit exists. Applying a patch is advised to resolve this issue.
Details
A vulnerability has been found in Oracle Siebel Clinical up to 8.2.2.x (Customer Relationship Management System) and classified as problematic. This vulnerability affects an unknown function of the component Web UI. As an impact it is known to affect integrity. CVE summarizes:
Unspecified vulnerability in the Siebel Clinical component in Oracle Industry Applications 7.7, 7.8, 8.0.0.x, 8.1.1.x, and 8.2.2.x allows remote authenticated users to affect integrity via unknown vectors related to Web UI.
The weakness was disclosed 04/17/2012 (Website). The advisory is shared for download at oracle.com. This vulnerability was named CVE-2012-1674 since 03/16/2012. The exploitation appears to be easy. The attack can be initiated remotely. The successful exploitation requires a single authentication. There are neither technical details nor an exploit publicly available.
The vulnerability scanner Nessus provides a plugin with the ID 58798 (Oracle Database Multiple Vulnerabilities (April 2012 CPU)), which helps to determine the existence of the flaw in a target environment. It is assigned to the family Databases and running in the context l.
Applying a patch is able to eliminate this problem. The bugfix is ready for download at oracle.com. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (58798), SecurityFocus (BID 53063†), Secunia (SA48885†) and SecurityTracker (ID 1026952†). The entries VDB-5110, VDB-5087, VDB-5112 and VDB-5111 are pretty similar. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: UnknownCWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 58798
Nessus Name: Oracle Database Multiple Vulnerabilities (April 2012 CPU)
Nessus File: 🔍
Nessus Risk: 🔍
Nessus Family: 🔍
Nessus Context: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: PatchStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Patch: oracle.com
Timeline
03/16/2012 🔍04/17/2012 🔍
04/17/2012 🔍
04/18/2012 🔍
04/18/2012 🔍
04/19/2012 🔍
05/03/2012 🔍
03/23/2021 🔍
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2012-1674 (🔍)
GCVE (CVE): GCVE-0-2012-1674
GCVE (VulDB): GCVE-100-5152
SecurityFocus: 53063
Secunia: 48885
SecurityTracker: 1026952
See also: 🔍
Entry
Created: 04/18/2012 22:00Updated: 03/23/2021 10:45
Changes: 04/18/2012 22:00 (53), 04/26/2018 11:05 (11), 03/23/2021 10:45 (3)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.